Some viruses help drug-resistant bacteria grow in the lungs of cystic fibrosis patients, new Stanford research shows.
A new policy brief from Stanford researchers identifies the connection between paid family leave and infant and maternal health benefits.
A new study has found that opioid-related deaths are highest on the East Coast and opioids are affecting an increasing number of African-Americans.
Experts studying nicotine and e-cigarette norms say that Juul has instigated a "nicotine arms race," causing a shift across the e-cigarette industry.
A Stanford study shows Hsp70 protein inhibitors can protect mice from Zika virus without developing drug resistance, demonstrating their clinical potential.
Scientists have pinpointed the ensemble of neurons that specifically gives rise to the unpleasantness of pain in the brain.
A new approach to identifying the factors linked to poverty could help researchers identify ways to prevent it.
As an African-American with chronic illness, Eric Sibley prevailed in academic medicine where few colleagues shared his challenges.
Small trial conducted by Stanford researchers links activity in the brain's reward processing system with drug relapse in patient cohort.
About 31 million U.S. adults have food allergies, nearly half of which develop after age 18, findings that surprised food allergy experts.
Patients who undergo physical therapy soon after a pain diagnosis are less likely to use opioids in the long term, a Stanford-Duke study finds.
Sharon Chinthrajah weighs in on a new peanut allergy immunotherapy, speaking to its potential and its role in the future of food allergies therapy.
An anti-smoking ad campaign featuring a woman with depression helps smokers with mental health conditions attempt to quit.
A government program providing market-value, noncash compensation to kidney donors would benefit poor people and not be exploitative, according to a study.
During a talk at Stanford, journalist and author Barry Meier discussed his nearly two-decade long investigation into OxyContin and Purdue Pharma.
A Stanford team has developed an algorithm that uses data about tumors to identify new classifications that can provide information about patient outcomes
